These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8880024)

  • 1. Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients.
    Cioffi G; Pozzoli M; Forni G; Franchini M; Opasich C; Cobelli F; Tavazzi L
    Eur Heart J; 1996 Sep; 17(9):1381-9. PubMed ID: 8880024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [SFAAT: the study of nonrheumatic chronic atrial fibrillation in the Trieste area. Results of an enrollment study].
    Scardi S; Mazzone C; Goldstein D; Pandullo C; Poletti A; Humar F; Pivotti F; De Santis C
    G Ital Cardiol; 1995 Feb; 25(2):173-82. PubMed ID: 7642022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet and anticoagulant therapy in the prevention of thromboemboli in chronic heart failure.
    Garg RK; Gheorghiade M; Jafri SM
    Prog Cardiovasc Dis; 1998; 41(3):225-36. PubMed ID: 9872608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboembolism in heart failure: who should be treated?
    Diet F; Erdmann E
    Eur J Heart Fail; 2000 Dec; 2(4):355-63. PubMed ID: 11113711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction.
    Baker DW; Wright RF
    JAMA; 1994 Nov 23-30; 272(20):1614-8. PubMed ID: 7966873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aspirin, oral anticoagulants, and heart failure].
    Gibelin P
    Arch Mal Coeur Vaiss; 1998 Nov; 91(11):1377-81. PubMed ID: 9864607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY; Wrigley BJ; Pisters R
    Cochrane Database Syst Rev; 2012 Jun; (6):CD003336. PubMed ID: 22696335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic study.
    Jaber WA; Prior DL; Thamilarasan M; Grimm RA; Thomas JD; Klein AL; Asher CR
    Am Heart J; 2000 Jul; 140(1):150-6. PubMed ID: 10874278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Freudenberger RS; Hellkamp AS; Halperin JL; Poole J; Anderson J; Johnson G; Mark DB; Lee KL; Bardy GH;
    Circulation; 2007 May; 115(20):2637-41. PubMed ID: 17485579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of thromboembolism in patients with mitral stenosis and associated atrial fibrillation: effectiveness of low intensity (INR target 2) oral anticoagulant treatment.
    Pengo V; Barbero F; Biasiolo A; Pegoraro C; Noventa F; Iliceto S
    Thromb Haemost; 2003 Apr; 89(4):760-4. PubMed ID: 12669133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic Substudy.
    Gupta DK; Giugliano RP; Ruff CT; Claggett B; Murphy S; Antman E; Mercuri MF; Braunwald E; Solomon SD;
    J Am Soc Echocardiogr; 2016 Jun; 29(6):537-44. PubMed ID: 27106009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk].
    Kottkamp H; Willems S; Hindricks G; Chen X; Haverkamp W; Hasfeld M; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioversion of persistent atrial flutter in non-anticoagulated patients at low risk for thromboembolism.
    Bertaglia E; D'Este D; Franceschi M; Pascotto P
    Ital Heart J; 2000 May; 1(5):349-53. PubMed ID: 10832811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heart failure and arrhythmia: modalities and indications of prevention of thromboembolism].
    Prati PL; Piazza V
    Cardiologia; 1994 Dec; 39(12 Suppl 1):353-6. PubMed ID: 7634296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low incidence of stroke in ambulatory patients with heart failure: a prospective study.
    Katz SD; Marantz PR; Biasucci L; Jondeau G; Lee K; Brennan C; LeJemtel TH
    Am Heart J; 1993 Jul; 126(1):141-6. PubMed ID: 8322656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy in patients with chronic heart failure: rationale, clinical evidence and practical implications.
    Dotsenko O; Kakkar VV
    J Thromb Haemost; 2007 Feb; 5(2):224-31. PubMed ID: 17067363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Occurrence of thromboembolic complications in patients with dilated cardiomyopathy. Retrospective-prospective study].
    Polić S; Biocić M; Lukin A; Rumboldt Z; Bagatin J; Pivac N; Rakić D; Naranca M
    Lijec Vjesn; 1997; 119(5-6):142-6. PubMed ID: 9379820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Oral Anticoagulants in Direct Current Cardioversion for Atrial Fibrillation.
    Femia G; Fetahovic T; Shetty P; Lee A
    Heart Lung Circ; 2018 Jul; 27(7):798-803. PubMed ID: 28802808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolism and antithrombotic therapy in congestive heart failure.
    Dunkman WB
    J Cardiovasc Risk; 1995 Apr; 2(2):107-17. PubMed ID: 7606647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
    Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.